Browse > Article

MOSFET Dosimetry for Evaluation of Gonad Shielding during Radiotherapy  

Kim, Hwi-Young (Department of Radiation Applied Life Science, Seoul National University College of Medicine)
Choi, Yun-Seok (Department of Radiation Applied Life Science, Seoul National University College of Medicine)
Park, So-Yeon (Department of Radiation Applied Life Science, Seoul National University College of Medicine)
Park, Yang-Kyun (Department of Radiation Applied Life Science, Seoul National University College of Medicine)
Ye, Sung-Joon (Department of Radiation Oncology, Seoul National University College of Medicine)
Publication Information
Journal of Radiation Protection and Research / v.36, no.1, 2011 , pp. 23-27 More about this Journal
Abstract
In order to confirm feasibility of MOSFET modality in use of in.vivo dosimetry, evaluation of gonad shielding in order to minimize gonadal dose of patients undergoing radiotherapy by using MOSFET modality was performed. Gonadal dose of patients undergoing radiotherapy for rectal cancer in the department of radiation oncology of Seoul National University Hospital since 2009 was measured. 6 MV and 15 MV photon beams emitted from Varian 21EX LINAC were used for radiotherapy. In order to minimize exposed dose caused by the scattered ray not only from collimator of LINAC but also from treatment region inside radiation field, we used box.shaped lead shielding material. The shielding material was made of the lead block and consists of $7.5\; cm\;{\times}\;9.5\;cm\;{\times}5.5\;cm$ sized case and $9\;cm\;{\times}\;9.5\;cm\;{\times}\;1\;cm$ sized cover. Dosimetry for evaluation of gonad shielding was done with MOSFET modality. By protecting with gonad shielding material, average gonadal dose of patients was decreased by 23.07% compared with reference dose outside of the shielding material. Average delivered gonadal dose inside the shielding material was 0.01 Gy. By the result of MOSFET dosimetry, we verified that gonadal dose was decreased by using gonad shielding material. In compare with TLD dosimetry, we could measure the exposed dose easily and precisely with MOSFET modality.
Keywords
Gonad shielding; MOSFET dosimetry; In.vivo dosimetry;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Fraass BA. Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield, Int. J. Radia. Oncol. Biol, Phys, 1985 Mar; 11(3):609-615.   DOI   ScienceOn
2 Essers M, Mijnheer BJ. In vivo dosimetry during external photon beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys, 1999 Jan;43(2):245-259.   DOI   ScienceOn
3 Ramani R, Russell S, O'Brien P. Clinical dosimetry using MOSFETs, Int. J. Radiat. Oncol. Biol, Phys, 1997 Mar;37(4):959-964.   DOI   ScienceOn
4 Choo SS, Seo CO, Kim GE. Shielding for Critical Organs and Radiation Exposure Dose Distribution in Patients with High Energy Radiotherapy. J. Korea Asso. Radiat. Prot. 2002;27(1):1-10.
5 Giessen PH. Calculation and measurement of the dose at points outside the primary beam for photon energies of 6, 10, and 23 MV. Int. J. Radiat. Oncol. Biol. Phys, 1994 Dec;30(5):1239-1246.   DOI   ScienceOn
6 Ash PJND. Non-stochastic effects of ionising radiations on gonads. J. Soc. Radiol. Prot. 1998 June;6(2):55-62.
7 Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia; Lippincott Williams & Wilkins, 2006.
8 National Council on Radiation Protection and Measurements. NCRP report : Recommendations on limits for exposure to ionizing radiation. Bethesda, MD; The Council. 1987.
9 International Commission on Radiological Protection. ICRP publication 103 : The 2007 Recommendations of the International Commission on Radiological Protection. Pergamon Press, 2007;37(2-4):1-332.